Document Detail

A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
MedLine Citation:
PMID:  20687123     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the influence of maternal insulin-dependent diabetes mellitus (IDDM) on maternal serum free ß-hCG, pregnancy-associated plasma protein-A (PAPP-A) and fetal nuchal translucency (NT) thickness from 11 weeks to 13 weeks 6 days of gestation in a large cohort of women screened prospectively for chromosomal anomalies.
METHODS: Information on maternal IDDM status, maternal serum biochemical marker levels and fetal NT were collected from the prenatal screening computer records. On total, the control group included 83,972 and the IDDM group included 489 pregnancies. The median-corrected free β-hCG and PAPP-A, expressed as MoM, and fetal NT, expressed as delta values, in the IDDM and non-IDDM groups were compared.
RESULTS: There were no significant differences between the IDDM and non-IDDM groups in median-corrected free β-hCG (IDDM 1.01 MoM, non-IDDM 1.01 MoM; p = 0.970), or mean delta NT (IDDM 0.00 mm, non-IDDM 0.02 mm; p = 0.412). However, the median-corrected PAPP-A was significantly lower (IDDM 0.88 MoM, non-IDDM 1.03 MoM; p < 0.0001).
CONCLUSIONS: In pregnancies with maternal IDDM, first-trimester screening for chromosomal defects does not require adjustments for the measured fetal NT and maternal serum free ß-hCG. However, for PAPP-A the 15% reduction is large enough to require correction in the calculation of risks for chromosomal defects.
K Spencer; N J Cowans; C E Spencer; N Achillea
Related Documents :
17518423 - Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome i...
10451523 - Fetal nuchal translucency and prenatal diagnosis of beta-thalassaemia.
22331333 - Maternal serum vitamin d levels during pregnancy and offspring neurocognitive development.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  30     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-29     Completed Date:  2011-01-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  937-40     Citation Subset:  IM    
Copyright Information:
© 2010 John Wiley & Sons, Ltd.
Prenatal Screening Unit, Clinical Biochemistry Department, Barking Havering & Redbridge University Hospitals, King George Hospital, Goodmayes, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / metabolism
Chorionic Gonadotropin, beta Subunit, Human / blood
Diabetes Mellitus, Type 1 / blood*,  ultrasonography
Down Syndrome / blood*,  ultrasonography
Genetic Counseling
Mass Screening
Nuchal Translucency Measurement
Pregnancy / blood*
Pregnancy Trimester, First / blood*
Pregnancy in Diabetics / blood*,  pathology,  ultrasonography
Pregnancy-Associated Plasma Protein-A / metabolism
Prospective Studies
Ultrasonography, Prenatal
Reg. No./Substance:
0/Biological Markers; 0/Chorionic Gonadotropin, beta Subunit, Human; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In vitro cardiomyogenic potential of human amniotic fluid stem cells.
Next Document:  Progenitor-derived endothelial cell response, platelet reactivity and haemocompatibility parameters ...